CHEMED ($CHE) posted quarterly earnings results on Tuesday, October 28th. The company reported earnings of $5.27 per share, missing estimates of $5.43 by $0.16. The company also reported revenue of $624,900,000, missing estimates of $632,293,835 by $-7,393,835.
You can see Quiver Quantitative's $CHE stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
CHEMED Insider Trading Activity
CHEMED insiders have traded $CHE stock on the open market 8 times in the past 6 months. Of those trades, 1 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $CHE stock by insiders over the last 6 months:
- NICHOLAS MICHAEL WESTFALL (Executive Vice President) sold 10,012 shares for an estimated $4,224,162
- KEVIN J MCNAMARA (president and CEO) has made 0 purchases and 3 sales selling 6,500 shares for an estimated $3,105,615.
- SPENCER S LEE (executive vice president) has made 0 purchases and 2 sales selling 3,000 shares for an estimated $1,733,775.
- GEORGE J III WALSH purchased 200 shares for an estimated $83,420
- PATRICK P GRACE sold 150 shares for an estimated $69,508
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
CHEMED Hedge Fund Activity
We have seen 267 institutional investors add shares of CHEMED stock to their portfolio, and 275 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- POINT72 ASSET MANAGEMENT, L.P. removed 128,684 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $62,660,100
- AQR CAPITAL MANAGEMENT LLC added 123,982 shares (+160.9%) to their portfolio in Q2 2025, for an estimated $60,370,555
- ACADIAN ASSET MANAGEMENT LLC added 102,597 shares (+69.3%) to their portfolio in Q2 2025, for an estimated $49,957,557
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC removed 102,464 shares (-23.2%) from their portfolio in Q2 2025, for an estimated $49,892,795
- FMR LLC removed 82,327 shares (-30.4%) from their portfolio in Q2 2025, for an estimated $40,087,486
- AMERIPRISE FINANCIAL INC removed 76,329 shares (-45.2%) from their portfolio in Q2 2025, for an estimated $37,166,879
- CAISSE DE DEPOT ET PLACEMENT DU QUEBEC added 67,956 shares (+297.7%) to their portfolio in Q2 2025, for an estimated $33,089,815
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
CHEMED Congressional Stock Trading
Members of Congress have traded $CHE stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $CHE stock by members of Congress over the last 6 months:
- REPRESENTATIVE LISA C. MCCLAIN purchased up to $15,000 on 06/24.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
CHEMED Analyst Ratings
Wall Street analysts have issued reports on $CHE in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- B of A Securities issued a "Buy" rating on 09/10/2025
- Jefferies issued a "Buy" rating on 09/02/2025
- Oppenheimer issued a "Outperform" rating on 07/31/2025
- RBC Capital issued a "Outperform" rating on 07/31/2025
To track analyst ratings and price targets for CHEMED, check out Quiver Quantitative's $CHE forecast page.
CHEMED Price Targets
Multiple analysts have issued price targets for $CHE recently. We have seen 4 analysts offer price targets for $CHE in the last 6 months, with a median target of $584.5.
Here are some recent targets:
- Joanna Gajuk from B of A Securities set a target price of $595.0 on 09/10/2025
- Brian Tanquilut from Jefferies set a target price of $550.0 on 09/02/2025
- Michael Wiederhorn from Oppenheimer set a target price of $580.0 on 07/31/2025
- Ben Hendrix from RBC Capital set a target price of $589.0 on 07/31/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
